• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

European Pharmaceutical Review Extra

The latest blogs, views and comments on the Pharma world from the leading experts in the industry…

 

zika-virus

Wanted: Zika virus researchers

Posted on: 10 February 2016 | Author: Victoria White, European Pharmaceutical Review

The MRC has launched a £1m rapid response funding initiative to better understand the nature of the risk posed by the Zika virus. Find out about this initiative and NIH's call for research here...

zika5

Zika Virus: a public emergency of international concern

Posted on: 4 February 2016 | Author: Victoria White, European Pharmaceutical Review

The Zika virus has taken hold in South America. Its possible link to microcephaly in newborn babies and neurological conditions has led the World Health Organization to declare a Public Health Emergency of International Concern. Here we discuss the virus, countermeasures and the race for a vaccine...

rmms

Emerging trends in microbiological diagnostics: an introduction to rapid microbiological methods

Posted on: 29 January 2016 | Author: Adewale Joseph Ogunleye, Adekunle Ajasin University, Akungba Akoko, Ondo State, Nigeria

This article explores how scientists are developing a fast, qualitative and specific technique for the detection and classification of microorganisms...

pharmaceutical industry

European Pharmaceutical Review’s top 10 stories from 2015

Posted on: 28 January 2016 | Author: Victoria White, Digital Content Producer, European Pharmaceutical Review

2015 was an interesting year for the pharmaceutical industry. Here we pick a selection of the top stories that hit the headlines...

ovarian cancer

FDA finally speeds up approval for ovarian cancer drugs

Posted on: 19 January 2016 | Author: Snehal Chougule, Allied Market Research

Snehal Chougule discusses the ovarian cancer treatment market and recent approvals by the US Food and Drug Administration...

universal flu vaccine

The universal flu vaccine race

Posted on: 5 January 2016 | Author: Victoria White, European Pharmaceutical Review

A number of pharmaceutical companies see great potential in a universal flu vaccine, each hoping they will be the first to gain regulatory approval of their candidates. European Pharmaceutical Review spoke with Gregory Stoloff, CEO of one such company, SEEK, to find out more...

pfizer

More pharma M&A to come?

Posted on: 25 November 2015 | Author: Garry White, Chief Investment Commentator, Charles Stanley

Viagra maker Pfizer announced on Monday that it would purchase Allergan, the Irish maker of Botox, for about $160bn – the biggest deal ever in the healthcare sector. Could more mega-mergers be in prospect?

visa

Immigration strategies for effectively relocating to the US

Posted on: 6 November 2015 | Author: Ashley Puscas, Associate Attorney at Laura Devine Attorneys

In our globalised economy, it is more common than ever to see pharma companies expanding to establish a presence in multiple markets. Here Ashley Puscas discusses the immigration pathways for pharma seeking to relocate or expand in the US...

cyber-security-in-pharmaceuticals

Cyber security in pharmaceuticals

Posted on: 22 October 2015 | Author: Caroline Rivett and Dr Cornelius Namiluko at KPMG

Dr Cornelius Namiluko and Caroline Rivett discuss cyber security in the pharmaceutical industry and the approaches companies can take to address the risk of a cyber attack...

patient-advocacy-adhd

2015 Excellence in ADHD Patient Group Awards: Patient advocacy at Shire

Posted on: 20 October 2015 | Author: Victoria White

In the run up to ADHD Awareness Week, European Pharmaceutical Review spoke with Tom Croce, Head of Global Patient Advocacy at Shire, to find out more about the awards and what makes Shire a 'patient-centric' company...

Laboratory Weighing

Improving revenue: Finding the right talent (part 2)

Posted on: 18 November 2013 | Author: Dr Kevin Robinson

The response to a lack of skilled managers is often to take a ‘sticking plaster’ approach to the problem by deciding to take on one or two pricing managers and have them report into the commercial or finance team. Experience to date shows that this will have limited success, for a number of reasons...

Woman Screening Assay Scientist

Improving revenue: Finding the right talent (part 1)

Posted on: 5 November 2013 | Author: Dr Kevin Robinson

Few markets have undergone the degree of change experienced by the life sciences sector in recent years. The end of the blockbuster drug era, the increasing cost of product development and a growing population putting greater strain on healthcare services around the world have combined at a time when economic constraints are putting fierce pressures on the public purse to do more with less...

  • Page 1 of 2
  • 1
  • 2
  • >

 

Webinar: Purity Determination of Pharmaceuticals by Thermal AnalysisWATCH NOW
+ +